[PDF][PDF] An Ontological Representation of Adverse Drug Events.
A standardized, controlled vocabulary allows adverse drug events (ADE) information to be
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
An ontological representation of adverse drug events
G Jiang, JD Duke, J Pathak… - CEUR Workshop …, 2011 - pure.johnshopkins.edu
A standardized, controlled vocabulary allows adverse drug events (ADE) information to be
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
An Ontological Representation of Adverse Drug Events
G Jiang - 2011 - pdfs.semanticscholar.org
An Ontological Representation of Adverse Drug Events Page 1 An Ontological
Representation of Adverse Drug Events Guoqian Jiang, PhD ©2011 MFMER | slide-1 …
Representation of Adverse Drug Events Guoqian Jiang, PhD ©2011 MFMER | slide-1 …
[PDF][PDF] An Ontological Representation of Adverse Drug Events
G Jiang, JD Duke, J Pathak, CG Chute - scholar.archive.org
A standardized, controlled vocabulary allows adverse drug events (ADE) information to be
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
[PDF][PDF] An Ontological Representation of Adverse Drug Events
G Jiang, JD Duke, J Pathak, CG Chute - ceur-ws.org
A standardized, controlled vocabulary allows adverse drug events (ADE) information to be
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
An ontological representation of adverse drug events
G Jiang, JD Duke, J Pathak… - CEUR Workshop …, 2011 - mayoclinic.elsevierpure.com
A standardized, controlled vocabulary allows adverse drug events (ADE) information to be
described in an unambiguous way in knowledge bases, which is critical for clinical decision …
described in an unambiguous way in knowledge bases, which is critical for clinical decision …